References
Amery A, DePlaen JF, Lijnen P, McAinsh J, Reybrouck T. Relationship between blood level of atenolol and pharmacologic effect. Clinical Pharmacology and Therapeutics 21: 691–699, 1977
Ayman D, Goldshine AD. Blood pressure determined by patients with essential hypertension: I. The difference between clinic and home readings before treatment. American Journal of the Medical Sciences 200: 465–474, 1940
Eggertsen R, Sivertsson R, Andrén L, Hansson L. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension. Journal of Hypertension 2: 529–534, 1984
Floras JS, Hassn MO, Jones JV, Sleight P. Ambulatory blood pressure and its variability during randomised double-blind administration of atenolol, metoprolol, pindolol and long acting propranolol in subjects with mild to moderate hypertension. Drugs 25 (Suppl. 2): 19–25, 1983
Freis ED. Hemodynamics in hypertension. Physiological Reviews 40: 27–54, 1960
Heber ME, Bridgen GS, Caruana MP, Lahiri A, Raftery EB. Carvedilol for systemic hypertension. American Journal of Cardiology 59: 400–405, 1987
James GD, Pickering TG, Yee LS, Harshfield GA, Riva S, et al. The reproducibility of average ambulatory, home, and clinic pressures. Hypertension 11: 545–549, 1988
Kaski JC, Rodriguez-Plaza L, Brown J, Maseri A. Efficacy of carvedilol (BM14190), a new beta-blocking drug with vasodilating properties in exercise-induced ischemia. American Journal of Cardiology 56: 35–40, 1985
Kincaid-Smith P. Beta-adrenergic blocking drugs in hypertension. American Journal of Cardiology 53: 12A-15A, 1984
Kincaid-Smith P. Vasodilator drugs in the treatment of hypertension. Medical Journal of Australia 142: 450–453, 1985
Koch-Weser J. Vasodilator drugs in the treatment of hypertension. Archives of Internal Medicine 133: 1017–1027, 1974
Lahiri A, Rodrigues EA, Al-Khawaja I, Raftery EB. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris. American Journal of Cardiology 59: 769–774, 1987
Littler WA, Honour AJ, Pugsley DJ, Sleight P. Continuous recording of direct arterial pressure in unrestricted patients. Circulation 51: 1101–1106, 1975
Mancia G, Zanchetti A. Blood pressure variability. In Zanchetti A, Tarazi RC (Eds) Handbook of hypertension: pathophysiology of hypertension — cardiovascular aspects, Vol. 9, pp. 125–152, Elsevier, 1986
Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, et al. Effects of blood pressure measurement by the doctor on patient’s blood pressure and heart rate. Lancet 2: 695–698, 1983
Mann S, Millar-Craig MW, Altman D, Melville D, Raftery EB. The effects of metoprolol on ambulatory blood pressure. Clinical Science 57 (Suppl. 5): 335–337, 1979
Mehta SK, Walsh JT, Moni K, Goldberg AD. Single daily dosage of acebutolol in hypertensives; the effect on the circadian rhythms as measured with 24-hour blood pressure monitoring. In Scott et al. (Eds) ISAM 1979, pp. 197–202, Academic Press, London, 1980
Meyer-Sabellek W, Schulte K-L, Distler A, Gotzen R. Acute hypotensive response to the new antihypertensive agent BM 14190 in essential hypertensive patients. Journal of Hypertension 1 (Suppl. 2): 351–352, 1983
Meyer-Sabellek W, Schulte K-L, Distler A, Gotzen R. Follow-up of a method of twenty-four-hour indirect blood pressure monitoring: evaluation of carvedilol, a new antihypertensive agent. Nephron 47 (Suppl. 1): 42–46, 1987
Meyer-Sabellek W, Schulte K-L, Distler A, Gotzen R. Methodological development and problems in indirect automated blood pressure monitoring. In Meyer-Sabellek et al. (Eds) Blood pressure measurement: new techniques in automatic indirect monitoring, Steinkopff Verlag, Darmstadt, in press
Möllendorf E, Abshagen U, Akpan W, Neugebauer G, Schröter E. Clinical pharmacological investigations with carvedilol, a new beta-blocker with direct vasodilator activity. Clinical Pharmacology and Therapeutics 39: 677–682, 1986
Parati G, Pomidossi G, Cascadei R, Trazzi S, Ravogli A, et al. Evaluation of the antihypertensive effect of celiprolol by ambulatory blood pressure monitoring. American Journal of Cardiology 61: 27C–33C, 1988
Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. Journal of the American Medical Association 249: 2792–2798, 1983
Pickering TG, Boddie C, James GD, Harshfield GA, Blank SS, Laragh JH. How common is white coat hypertension? Journal of the American Medical Association 259: 2256–2258, 1988
Rotmensch HH, Rocci ML, Vlasses PH, Swanson BN, Fedder IL, et al. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension. American Journal of Cardiology 54: 353–356, 1984
Sponer G, Muller-Beckmann B. Studies on the mechanism of the vasodilating activity of BM 14.190 (Abstr.). Naunyn Schmiedebergs Archives of Pharmacology 32: (Suppl.): R45, 1983
Taylor SH. Celiprolol in hypertension. American Heart Journal 116: 1426–1434, 1988
van den Meiracker A, Man in’t Veld A, Schalekamp MAD. Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24h haemodynamic study. British Journal of Clinical Pharmacology 24: 39S–44S, 1987
van Zwieten PA. The role of adrenoceptors in circulatory and metabolic regulation. American Heart Journal 116: 1384–1392, 1988
Watson RDS, Stallard TJ, Littler W. Influence of once daily administration of a beta-adrenoceptor antagonist on arterial pressure and its variability. Lancet 1: 1210–1213, 1979
Weber MA, Drayer JIM, Wyle FA, De Young JL. Reproducibility of the whole-day blood pressure pattern in essential hypertension. Clinical and Experimental Hypertension A 4: 1377–1380, 1982
Weidmann P, Gerber A, Mordasini R. Effects of antihypertensive therapy on serum lipoproteins. Hypertension 5 (Suppl. 3): 120–131, 1983
West MJ, Sleight P, Honour AJ. Clinical trial of the beta-adrenoceptor blocking agent tolamolol with the use of 24 hour blood pressure recordings. Clinical Science and Molecular Medicine 51: 545S–547S, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meyer-Sabellek, W., Schulte, KL., Streitberg, B. et al. Two-Year Follow-Up of 24-Hour Indirect Blood Pressure Monitoring: An Open Study. Drugs 36 (Suppl 6), 106–112 (1988). https://doi.org/10.2165/00003495-198800366-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800366-00018